» Articles » PMID: 35861938

Human Adenovirus (HAdV) Infection in Children with Acute Respiratory Tract Infections in Guangzhou, China, 2010-2021: a Molecular Epidemiology Study

Abstract

Background: Human adenovirus (HAdV) infection can cause a variety of diseases. It is a major pathogen of pediatric acute respiratory tract infections (ARIs) and can be life-threatening in younger children. We described the epidemiology and subtypes shifting of HAdV among children with ARI in Guangzhou, China.

Methods: We conducted a retrospective study of 161,079 children diagnosed with acute respiratory illness at the Guangzhou Women and Children's Medical Center between 2010 and 2021. HAdV specimens were detected by real-time PCR and the hexon gene was used for phylogenetic analysis.

Results: Before the COVID-19 outbreak in Guangzhou, the annual frequency of adenovirus infection detected during this period ranged from 3.92% to 13.58%, with an epidemic peak every four to five years. HAdV demonstrated a clear seasonal distribution, with the lowest positivity in March and peaking during summer (July or August) every year. A significant increase in HAdV cases was recorded for 2018 and 2019, which coincided with a shift in the dominant HAdV subtype from HAdV-3 to HAdV-7. The latter was associated with a more severe disease compared to HAdV-3. The average mortality proportion for children infected with HAdV from 2016 to 2019 was 0.38% but increased to 20% in severe cases. After COVID-19 emerged, HAdV cases dropped to 2.68%, suggesting that non-pharmaceutical interventions probably reduced the transmission of HAdV in the community.

Conclusion: Our study provides the foundation for the understanding of the epidemiology of HAdV and its associated risks in children in Southern China.

Citing Articles

Construction of a bivalent vaccine candidate against HAdV4/HAdV7 based on capsid-display strategy via Red-homologous recombination and counter-selection methodology.

Wang P, Shao Y, Yang X, Zhang W, Zhou J, Huang F Biosaf Health. 2025; 6(2):70-79.

PMID: 40078946 PMC: 11895023. DOI: 10.1016/j.bsheal.2024.02.001.


Impact of co-infections and immune responses on clinical severity of human adenovirus 3 and 7 infections in hospitalized children with lower respiratory tract infections: a comparative study.

Ma X, Wu Y, De R, Yao H, He F, Wang Y Front Cell Infect Microbiol. 2025; 14():1482787.

PMID: 39850965 PMC: 11754186. DOI: 10.3389/fcimb.2024.1482787.


Immunological pathogenesis and treatment progress of adenovirus pneumonia in children.

Liang Y, Wei J, Shen J, Liang Z, Ma X, Du Y Ital J Pediatr. 2025; 51(1):4.

PMID: 39789604 PMC: 11715079. DOI: 10.1186/s13052-024-01836-1.


Mycoplasma pneumoniae detections in children with lower respiratory infection before and during the COVID-19 pandemic: a large sample study in China from 2019 to 2022.

Qiu W, Ding J, Zhang H, Huang S, Huang Z, Lin M BMC Infect Dis. 2024; 24(1):549.

PMID: 38824572 PMC: 11143586. DOI: 10.1186/s12879-024-09438-2.


Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications.

Scarsella L, Ehrke-Schulz E, Paulussen M, Thal S, Ehrhardt A, Aydin M Viruses. 2024; 16(3).

PMID: 38543743 PMC: 10974029. DOI: 10.3390/v16030377.


References
1.
Deng J, Qian Y, Zhao L, Zhu R, Sun Y, Tian R . [Identification and typing of adenovirus from acute respiratory infections in pediatric patients in Beijing from 2003 to 2012]. Bing Du Xue Bao. 2014; 29(6):615-20. View

2.
Tang L, An J, Yu P, Xu W . Complete genome sequence of human adenovirus type 7 associated with fatal infant pneumonia. Genome Announc. 2013; 1(1). PMC: 3569294. DOI: 10.1128/genomeA.00182-12. View

3.
Peng H, Chen F, Dang R, Zuo Y, Hu P, Yang Y . [Effect of high-titer plasma in pediatric patients with severe adenovirus pneumonia]. Zhonghua Er Ke Za Zhi. 2020; 58(5):392-397. DOI: 10.3760/cma.j.cn112140-20191111-00713. View